{"id":"W3025072273","doi":"10.3324/haematol.2019.238675","title":"Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC","funders":"National Cancer Institute","keywords":"Brentuximab vedotin; Medicine; Rituximab; Prednisone; Internal medicine; Cyclophosphamide; Oncology; Lymphoma; Vincristine; Regimen; B-cell lymphoma; CD30; Gastroenterology; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004202192,0.0003696617,0.0008370081,0.00006862287,0.000105284,0.00003243612,0.0000578528,0.0001138961,0.00003458107],"category_scores_gemma":[0.00004235106,0.0002214681,0.00006868303,0.0001922772,0.0001041228,0.00009375325,0.0000343443,0.00005500459,0.00002527591],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002689426,"about_ca_system_score_gemma":0.0001173219,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002005495,"about_ca_topic_score_gemma":0.00005118127,"domain_scores_codex":[0.998407,0.00004384722,0.0003334563,0.0006079279,0.0002581957,0.0003495748],"domain_scores_gemma":[0.9990737,0.0001717903,0.0001793184,0.0001944818,0.0001494484,0.000231258],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01118112,0.01973412,0.9577095,0.0002129583,0.0002722714,0.0006670599,0.001159441,0.000008398819,0.00004499089,0.001023495,0.0003315194,0.007655157],"study_design_scores_gemma":[0.1658274,0.03665416,0.7797129,0.0003938561,0.0006355682,0.000138196,0.0003308041,0.0005423136,0.01389317,0.0001863701,0.00122269,0.0004625673],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923426,0.0009170971,0.00008963701,0.002496255,0.00002628489,0.002901805,0.00008031206,0.00008242172,0.001063609],"genre_scores_gemma":[0.9940879,0.000205684,0.003765098,0.000780478,0.00001794045,0.0006078421,0.0004193103,0.00003418715,0.00008157799],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1779965,"threshold_uncertainty_score":0.9031207,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01012370075675274,"score_gpt":0.2260793674792768,"score_spread":0.215955666722524,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}